Stefan N. Lukianov, MS, AM is the founder, president and CEO of Salve Therapeutics, a biotechnology startup in Los Angeles, CA building viral biologics using computational tools. He completed his undergraduate work at the University of Maine, earning dual bachelor’s degrees in biochemistry and molecular and cellular biology. He also has dual master’s degrees in virology and biochemistry from the University of Pittsburgh and Harvard University, respectively. Stefan’s publishing experience spans respected academic journals and the general audience science press, and he has spent ample time teaching and tutoring in STEM fields, granting him unique science communication skills that contribute to his businesses’ development.